About Baird
Families & Individuals
Corporations & Institutions
Baird Research & Insights
Contact Us
Client Login
Individuals - Baird OnLine
Institutions
Corporations & Institutions
Investment Banking
M&A Recent Transactions
Deal Card
Investment Banking
Conferences
Asset Management
Private Equity
Fixed Income Sales and Trading
Equity Sales and Trading
Executive Services
Public Finance
Corporate Services
Institutional Consulting
Contact Us
Mergers and Acquisitions
Equity Financing
Corporate Restructuring
Industries of Focus
Financial Sponsors
Team Bios
News
Investment Banking Accolades
M&A Expertise
M&A Services
M&A Recent Transactions
Equity Financing Expertise
Equity Financing Services
Recent Financing Transactions
Corporate Restructuring Expertise
Corporate Restructuring Services
Business Services
Clean Technology
Consumer
Distribution
Energy
Financial Services
Healthcare
Industrial
Real Estate
Technology
Utilities
Financial Sponsors Recent Transactions
Here's the Deal
Baird's Investment Banking Group is pleased to announce the following transaction:
March 2012
Kforce Inc.
Sale of Kforce Clinical Research, Inc. to inVentiv Health, Inc.
Baird served as the exclusive financial advisor to Kforce Inc.
Kforce Inc. (NASDAQ-GS: KFRC) (“Kforce” or the “Company”) completed the sale of its wholly owned subsidiary, Kforce Clinical Research, Inc. (“KCR”), to inVentiv Health, Inc. (“inVentiv”).
Kforce is a professional staffing and solutions firm providing flexible and permanent staffing solutions in the skill areas of technology, finance & accounting, and health and life sciences. Kforce has over 2,200 associates and approximately 11,000 consultants on assignment. The Company operates from 63 offices located throughout the United States and one in the Philippines. KCR is a provider of functional outsourcing solutions to pharmaceutical, biotech and medical device companies. KCR will be combined with inVentiv’s existing functional service provider and staffing businesses within its Clinical segment. Kforce is headquartered in Tampa, Florida.
inVentiv is a global provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv's client roster includes more than 550 pharmaceutical, biotech and life sciences companies. inVentiv has 13,000 employees in 40 countries and is privately owned by inVentiv Group Holdings Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv management team.
For additional information about this transaction, please contact:
Managing Director
(312) 609-4965
Director
(312) 609-5475
Vice President
(312) 609-4968
Careers
|
Help
|
Site Map
|
Important Disclosures
|
Privacy Policy
|
Financial Information
|
Business Continuity
©2013 Robert W. Baird & Co. Incorporated.
Global Websites:
Europe
|
Asia
The services featured on this Web site may not be available in all jurisdictions or to all persons/entities. For more information, please see
Important Disclosures
. Robert W. Baird & Co. Incorporated. Member
SIPC
.